Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Aakaar Medical Technologies IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Aakaar Medical Technologies IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 6.13 and post-issue EPS of ₹ 4.26 for FY24. The pre-issue P/E ratio is 11.74x, while the post-issue P/E ratio is 16.90x. The company's ROCE for FY24 is 21.02%, ROE for FY24 is 33.81% and RoNW is 33.81%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹ 6.13 |
| EPS Post IPO (Rs.) | ₹ 4.26 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 11.74 |
| P/E Post IPO | 16.90 |
| Adjusted 12M P/E Post IPO | |
| ROE | 33.81 % |
| ROCE | 21.02 % |
| P/BV | 2.03 |
| Debt/Equity | 0.98 |
| RoNW | 33.81 % |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
